CRAFT-EP for Psychosis and Substance Use
Trial Summary
What is the purpose of this trial?
The purpose of this study is to evaluate Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) for families experiencing early psychosis and substance use delivered exclusively or primarily via telehealth (video conferencing).
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment CRAFT-EP for psychosis and substance use?
The study on telehealth CRAFT-EP for early psychosis and substance use showed that participants completed all sessions and rated the program satisfaction as excellent for nearly all sessions, indicating it is feasible and well-received. Additionally, CRAFT has been effective in engaging individuals with alcohol dependence in treatment, suggesting its potential usefulness in similar contexts.12345
Is CRAFT-EP safe for humans?
How is the CRAFT-EP treatment different from other treatments for psychosis and substance use?
Research Team
Julie M McCarthy, PhD
Principal Investigator
Mclean Hospital
Eligibility Criteria
This trial is for individuals aged 18-70 who have used alcohol or cannabis in the past month, are not currently interested in quitting substance use, and have experienced early psychosis within the last six years. Family members concerned about their relative's substance use can participate if they speak English, can consent, and have video conferencing tools.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) with 8 weekly sessions of 60-90-minute coaching
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- CRAFT-EP
- TAU
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mclean Hospital
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator